Meaning
The self-assembly and clustering of polypeptide chains into disordered structures or crystalline fibrils can occur during the thermal processing of bio-based polymers. In the production of protein-based bioplastics, protein aggregation represents an important mechanism that affects both material clarity and mechanical strength. This clustering is driven by hydrophobic interactions and hydrogen bonding.
Processing Impact
High shear forces and elevated temperatures during extrusion can destabilize the native conformation of the proteins. When protein aggregation occurs during the compounding of bio-polymers, it creates rigid, insoluble domains that act as stress concentrators. These domains make the resulting molded parts highly brittle.
Surface Interaction
In medical applications, the adsorption of biomolecules onto the surface of molded plastic syringes or tubes can trigger structural changes. Minimizing protein aggregation on the inner walls of these polymer housings is critical for preserving the potency of liquid biopharmaceuticals. This requires the use of specialized surface treatments or high-purity resins.
Mitigation Strategy
Adding plasticizers and control agents like glycerol or urea during compounding helps to stabilize the molecular structure and prevent the formation of large clusters. When managing protein aggregation in bio-based films, processors monitor the melt temperature and shear rates within the extruder. Keeping these variables within narrow limits ensures a homogeneous morphology and prevents the formation of visible defects or haze.
This preservation of material structure is essential for producing functional packaging.